Darren K. McGuire, MD, MHSc
Professor in the Department of Internal Medicine at UT Southwestern Medical Center
Director of the Parkland Hospital and Health System Outpatient Cardiology clinics.
Overview:
Review of the regulatory landscape for drugs for type 2 diabetes and how recent and ongoing cardiovascular trials have impacted clinical care for patients with type 2 diabetes.
Objectives:
At the conclusion of the activity a participant should be able to:
- To review the history of FDA regulation of drugs for type 2 diabetes
- To summarize available data from completed CV outcomes trials in patients with type 2 diabetes.
- To review contemporary specialty society recommendations and guidelines regarding the use of antihyperglycemic medications for cardiovascular and kidney disease risk mitigation
Disclosures:
Darren K. McGuire, MD, MHSc was an Honoraria for clinical trial leadership for Afimmune and Sanofi. He is currently an Honoraria for clinical trial leadership for Boehringer Ingelheim, Merck & Co, Pfizer, AstraZeneca, Novo Nordisk, Esperion, and Lilly US. Dr. McGuire was an Honoraria for consultancy for Merck & Co, Applied Therapeutics, Metavant, Sanofi, and Affimmune. He is still an Honoraria for consultancy for Lilly USA, Boehringer Ingelheim, Novo Nordisk, Bayer, GlaxoSmithKline, Lexicon, Altimmune, and Esperion. Dr. McGuire was an Honoraria for Expert Testimony for Kirkland & Ellis: for the benefit of Boehringer Ingelheim (2020); Teva Pharmaceuticals (2021)
The Planning Committee has nothing to disclose relevant to this program.
The THI CME Staff has nothing to disclose relevant to this program.
The Program Reviewers has nothing to disclose relevant to this program.
Accreditation
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year.
Series attendees include Cardiology Fellows and Faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. We live broadcast Grand Rounds for online viewing on any desktop computer or mobile device.
Live Webcasting
Register for Livestream and Reminders (Required to receive link by email)
2022-23 Faculty Schedule
2022-23 Grand Rounds Event Calendar
Obtain CME Credit
Accreditation and Credit Designation
Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Visit THI CME Portal
Questions? Contact CME@texasheart.org
